Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 3Withdrawn 2Terminated 2Recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 989Neoplasms 848Carcinoma, Non-Small-Cell Lung 842Prostatic Neoplasms 527Neoplasm Metastasis 500Leukemia, Myeloid, Acute 488Melanoma 453Colorectal Neoplasms 446Multiple Myeloma 440Lung Neoplasms 419Pancreatic Neoplasms 352Recurrence 350Lymphoma 349Ovarian Neoplasms 341Lymphoma, Non-Hodgkin 327Leukemia 323Leukemia, Lymphocytic, Chronic, B-Cell 301Precursor Cell Lymphoblastic Leukemia-Lymphoma 271Carcinoma, Renal Cell 256Head and Neck Neoplasms 246Brain Neoplasms 243Carcinoma, Hepatocellular 234Squamous Cell Carcinoma of Head and Neck 231Glioblastoma 231Myelodysplastic Syndromes 229Lymphoma, Large B-Cell, Diffuse 228Lymphoma, Follicular 219Colonic Neoplasms 191Stomach Neoplasms 182Rectal Neoplasms 175

Interventions

Secretin 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interventional × Peutz-Jeghers Syndrome × Clear all
NCT00811590 2024-09-19

Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome

University of Utah

Phase 2 Terminated
3 enrolled 4 charts

Neoplasms, Peutz-Jeghers Syndrome, Polyps

NCT00587132 2013-06-24

Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma

Mayo Clinic

Phase 1/2 Terminated
4 enrolled 2 charts
Gastrointestinal

Diabetes Mellitus, Pancreatic Neoplasms, Peutz-Jeghers Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡